CD4 and neoplasm: In triple-negative breast cancer models, combining PB Lipo–PDT with PD-L1 blockade markedly increased intratumoral CD4+/CD8+ T-cell infiltration and achieved ~79% tumor growth inhibition (Figure 5G,H) [141].